SKSedef Kır

Sedef Kır

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sedef Kır has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Metabolomic Studies in Girls With Central and Peripheral Precocious Puberty

    by Aylin Balci Özyurt, Tuba Reçber, Emirhan Nemutlu, Derya Buluş, Sedef Kir, Belma Koçer Gümüşel, Pınar Erkekoğlu

    Puberte prekoks (PP), kızlarda sekonder cinsel özelliklerin sekiz yaşından önce başlamasıdır. Hipotalamus hipofiz-gonad ekseninin erken aktivasyonu nedeniyle "merkezi puberte prekoks (CPP)" meydana gelir. "Periferik puberte prekoks (PPP)" hipotalamus-hipofiz-gonad (HPG) aksına bağlı olmayan daha nadir görülen farklı bir durumdur ve periferik nedenlere bağlıdır. Metabolomiks, küçük molekül metabolitlerinin (<1000 Da) belirli bir süre içinde tanımlanması ve nicelendirilmesidir. Bu çalışmada CPP (n=50) ve PPP (n=47) tanısı alan kız çocukların plazma ve idrar metabolik profillerinin belirlenmesi ve sonuçlarının kontrol grubu (n=50) ile karşılaştırılması amaçlanmıştır. Metabolomik analiz, gaz kromatografisi-kütle spektrometresi kullanılarak yapılmıştır. Karmaşık kromatogramlar ayrıştırıldıktan ve düzenlendiken sonra, metabolitler tutunma indeksi kitaplıkları kullanılarak tanımlanmıştır. Sonuçlar, tek değişkenli ve çok değişkenli analiz kullanılarak istatistiksel olarak değerlendirilmiştir. Gruplar arasında ikili karşılaştırmalar yapılmış ve amino asitlerin metabolitlerinin gruplar arasında önemli ölçüde farklı olduğu bulunmuştur. Bu metabolitlerdeki değişiklikler potansiyel PP biyobelirteçleri olarak önerilebilir; ancak bu verileri doğrulamak ve validasyon için daha kapsamlı çalışmalara ihtiyaç vardır. Gelecekte, farklı hastalıkların, özellikle endokrin kaynaklı olanların altında yatan metabolik değişikliklerin, mekanistik toksikolojik çalışmalarla değerlendirilmesi gerekmektedir. Bu, araştırmacıların özellikle PP için yeni tedavi seçenekleri geliştirmelerine yardımcı olacaktır.

  • Open Access

    Metabolic Infrastructure of Pregnant Women with Fetuses Having Nervous System Abnormalities; Metabolomic Analysis

    by Tuba Reçber, Emirhan Nemutlu, Emine Aydın, Murat Cagan, Hanife Güler Dönmez, Sedef Kır, M.SInan Beksac

    Central nervous system diseases are neurological disorders that affect the structure or function of the brain and spinal cord that make up the central nervous system. In this study, it was aimed to examine the impaired/altered metabolomic profiles of pregnant women carrying fetuses with nervous system abnormalities (NSA). The study group consisted of 30 normal pregnancies with normal fetuses (control group) and 8 pregnancies with fetuses having NSA (study group), as determined by prenatal screening and diagnosis as part of an antenatal care program. Metabolomic analyses were carried out using gas chromatography-mass spectrometry (GC-MS). GC-MS-based metabolomics analysis was able to identify 95 metabolites and 27 of them were statistically significant between the two groups (p<0.05). Moreover, the pathway analysis, performed with significantly altered metabolites, showed alteration in the alanine, aspartate, and glutamate metabolism, citrate cycle, aminoacyl t-RNA biosynthesis, and glutathione metabolism. Alanine, aspartate and glutamate metabolism, citrate cycle, aminoacyl t-RNA biosynthesis, and glutathione metabolism seem to be critical in the prenatal screening of NSAs. However, abnormality-specific studies are necessary for further recommendations.

  • Open Access

    Development and validation of a sensitive assay for the quantification of arachidonoylcyclopropylamide (ACPA) in cell culture by LC–MS/MS

    by Özge Boyacıoğlu, Tuba Reçber, Sedef Kır, Petek Korkusuz, Emirhan Nemutlu

    Synthetic and natural cannabinoid derivatives are highly investigated as drug candidates due to their antinociceptive, antiepileptic and anticancer potential. Arachidonoylcyclopropylamide (ACPA) is a synthetic cannabinoid with antiproliferative and apoptotic effects on non-small cell lung cancer and pancreatic and endometrial carcinoma. Thus, ACPA has a great potential for being used as an anticancer drug for epithelial cancers. Therefore, determining the levels of ACPA in biological fluids, cells, tissues and pharmaceutical dosage forms is crucial in monitoring the effects of various pharmacological, physiological and pathological stimuli on biological systems. However, the challenge in the quantification of ACPA is its short half-life and lack of UV signal. Therefore, we developed a liquid chromatography-tandem mass spectrometric (LC–MS/MS) method for sensitive and selective quantification of ACPA in cell culture medium and intracellular matrix. Multiple reaction monitoring in the positive ionization mode was used for detection with 344 → 203 m/z transitions. The separation of ACPA was performed on C18 column (50 × 3.0 mm, 2.1 μm) with the mobile phase run in the gradient mode with 0.1% formic acid (FA) in water and 0.1% FA in acetonitrile at a flow rate of 0.3 ml/min. The assay was linear in the concentration range of 1.8–1000 ng/mL (r = 0.999). The validation studies revealed that the method was linear, sensitive, accurate, precise, selective, repeatable, robust and rugged. Finally, the developed method was applied to quantify ACPA in cell culture medium and intracellular matrix.


  • Analysis of Quinolones in Biological Materials by Liquid Chromatography

    by Elif Damla Gök, Sedef Kır, Emirhan Nemutlu

    Background: Quinolones are an important group of synthetic antibiotics with bactericidal action. The antibacterial activity of these compounds has been shown to result from selective inhibition of bacterial DNA synthesis. It is a preferable option in clinical use because of its efficacy, reliability and wide antibacterial spectrum. The identification and quantification of quinolones in various biological tissues and fluids is needed. Methods: Numerous techniques have been developed for their analysis in biological materials and pharmaceutical dosage forms. In this review, the chromatographic methods published in the last ten years for the analysis of quinolones, using for the treatment of an infection in a human, were reviewed. Results: The analysis methods of quinolones as single or simultaneous in biological materials were summarized according to sample preparation, chromatographic conditions, validation parameters and applicability of the methods. The pH effect on the chromatographic behaviors of quinolones was discussed. Moreover, multivariate analysis was performed for the summarized the published methods based on the method parameters. Conclusions: Many rapid and efficient separation methods have been developed for individual or simultaneous determination of quinolone. In this study, a comprehensive review is presented for the analysis of quinolone developed in the last decade.


  • Open Access

    Characterization of human bone marrow niches with metabolome and transcriptome profiling

    by Selda Ayhan, Emirhan Nemutlu, Duygu Uçkan Çetinkaya, Sedef Kır, Rıza Köksal Özgül

    Bone marrow (BM) niches are special microenvironments that work in harmony with each other for the regulation and maintenance of hematopoiesis. Niche investigations have thus far been limited to various model organisms and animal studies; therefore, little is known about different niches in healthy humans. In this study, a special harvesting method for the collection of BM from two different anatomical regions in the iliac crest of humans was used to investigate the presence of different niches in BM. Additionally, metabolomic and transcriptomic profiles were compiled using comparative ‘omics’ technologies, and the main cellular pathways and corresponding transcripts and metabolites were identified. As a result, we found that the energy metabolism between the regions was different. This study provides basic broad data for regenerative medicine in terms of the design of the appropriate microenvironment for in vitro hematopoietic niche modeling, and identifies the normal reference values that can be compared in hematological disease.


  • Determination and Validation of Aprepitant in Rat Plasma using LC−MS/MS

    by Nazlı Erdoğar, Tuba Reçber, Alper B İsKit, Erem Bilensoy, Sedef Kır, Emirhan Nemutlu

    Aim: The assessment of efficacy should be paralleled with extensive pharmacokinetic parameters, and a valid bioanalytical method is a pre-condition for accurate plasma concentration. Materials & me...


  • Ultrafiltration-based Extraction and LC-MS/MS Quantification of Phenylalanine in Human Blood Sample for Metabolite Target Analysis

    by Mustafa Çelebier, Tuba Reçber, Emirhan Nemutlu, Sedef Kır

    Background: Phenylalanine is a significant biomarker for various diseases like phenylketonuria, gastric cancers, and ischemic stroke according to recent studies. Methods: In the present study; a simple, sensitive, selective and novel analytical method was validated by using an ultrafiltration-based extraction and LC-MS/MS quantification of phenylalanine in human plasma using 13C phenylalanine heavy isotope. Amicon® Ultra Centrifugal Filter was used for ultrafiltration. Parameters affecting LC separation and MS/MS detection were investigated and optimized. Chromatographic separation was achieved on a Merck SeQuant ZIC-HILIC (100x4.6 mm, 5 μm) at a column temperature of 40°C using a mobile phase of mixture of acetonitrile containing 0.1% formic acid and water containing 0.1% formic acid (50:50 v/v) at a flow rate of 0.35 mL/min. The transitions m/z 167→121 for 13C phenylalanine, m/z 166→120 for phenylalanine itself were monitored using the MRM mode. Result: The assay was linear concentration range of 0.0025 μg/mL to 1.20 μg/mL (R2=0.999). The developed method was validated according to FDA guidelines. The method was found linear, sensitive, precise, accurate, and selective.

  • GC-MS Based Metabolic Profiling of Parkinson’s Disease with Glutathione S-transferase M1 and T1 Polymorphism in Tunisian Patients

    by Amal Rebai, Tuba Reçber, Emirhan Nemutlu, Chahra Chbili, Sevinç Kurbanoglu, Sedef Kir, Sana B. Amor, Sibel A. Özkan, Saad Saguem

    Aim and Objective: Parkinson’s disease (PD) is the second most common neurodegenerative disease. It is a multifactorial disorder (caused by aging, environmental, and genetic factors). Metabolomics can help explore the biomarker profiles for aging. Recent studies showed an association between the glutathione S-transferases (GSTs) polymorphisms and PD risk. The purpose of this study was to evaluate the association of this genetic polymorphism and the metabolomic profile in PD Tunisian patients, in order to identify effective biomarkers in the genetic differentiation. Materials and Methods: In this study, the metabolomic profile changes related to GSTs polymorphism were searched in 54 Tunisian PD patients treated with L-dopa, using a gas chromatography-mass spectrometry (GC-MS) technique. Results: The study results showed that mannose, methyl stearate, and three other unknown metabolites, increased in patients with GSTM1 positive genotype, while glycolic acid, porphine, monomethyl phosphate, fumaric acid, and three other unknown metabolites decreased in patients with GSTM1 positive genotype. Subsequently, the levels of glycolic acid, erythronic acid, lactic acid, citric acid, fructose, stearic acid, 2-amino-2-methyl-1,3-propanediol and three other unknown metabolites increased in patients with GSTM1 positive genotype, while the levels of proline, valine and two unknown metabolites decreased with GSTT1 positive genotype. Conclusion: All these altered metabolites are related to energy metabolism and it can be concluded that GSTs polymorphism based the shifting in energy metabolism and led to oxidative stress.


  • Metabolic infrastructure of pregnant women with methylenetetrahydrofolate reductase polymorphisms: A metabolomic analysis

    by Tuba Recber, Gokcen Orgul, Emine Aydın, Atakan Tanacan, Emirhan Nemutlu, Sedef Kır, Mehmet Sinan Beksac

    The aim of this study was to demonstrate the altered metabolic infrastructure of pregnant women with methylenetetrahydrofolate reductase (MTHFR) polymorphisms at first trimester and during delivery. Eight singleton pregnant women with MTHFR polymorphisms were compared with 10 normal pregnant women. Maternal blood samples were obtained twice during their pregnancy period (between the 11th and 14th gestational weeks and during delivery). Metabolomic analysis was performed using GC–MS. The GC–MS based metabolomic profile helped identify 95 metabolites in the plasma samples. In the MTHFR group, the levels of 1‐monohexadecanoylglycerol, pyrophosphate, benzoin, and linoleic acid significantly decreased (P ˂ 0.05 for all), whereas the levels of glyceric acid, l‐tryptophan, l‐alanine, l‐proline, norvaline, l‐threonine, and myo‐inositol significantly increased (P ˂ 0.01 for the first two metabolites, P ˂ 0.05 for the others) at 11–14 gestational weeks. Conversely, the levels of benzoin, 1‐monohexadecanoylglycerol, pyruvic acid, l‐proline, phosphoric acid, epsilon‐caprolactam, and pipecolic acid significantly decreased in the MTHFR group, whereas metabolites such as hexadecanoic acid and 2‐hydroxybutyric acid increased significantly in the study group during delivery. An impaired energy metabolism pathway, vitamin B complex disorders, tendency for metabolic acidosis (oxidative stress), and the need for cell/tissue support seem prevalent in pregnancies with MTHFR polymorphisms.